NADPH oxidases and atherosclerosis: unraveling the details
- PMID: 19897705
- PMCID: PMC3774417
- DOI: 10.1152/ajpheart.01020.2009
NADPH oxidases and atherosclerosis: unraveling the details
Comment on
-
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H24-32. doi: 10.1152/ajpheart.00799.2009. Epub 2009 Oct 16. Am J Physiol Heart Circ Physiol. 2010. PMID: 19837950
References
-
- Ambasta RK, Schreiber JG, Janiszewski M, Busse R, Brandes RP Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med 41: 193–201, 2006 - PubMed
-
- Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS Mitochondrial integrity and function in atherogenesis. Circulation 106: 544–549, 2002 - PubMed
-
- Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH Decreased blood pressure in NOX1-deficient mice. FEBS Lett 80: 497–504, 2006 - PubMed
-
- Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535–2552, 2009 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical